Results 231 to 240 of about 96,331 (301)

The unsung hero: <i>ntnh</i> gene as complementary botulism marker. [PDF]

Front Cell Infect Microbiol
Valdezate S, Valiente M, Díaz-Ramón S, Carrasco G, Medina-Pascual MJ, Pardos J, Hurtado MI, Garrido N, Villalón P, Martín-Galiano AJ.   +9 more
europepmc   +1 more source

A local outbreak of iatrogenic botulism associated with cosmetic injections of botulinum neurotoxin-containing products, England, 2025. [PDF]

Euro Surveill
Jasperse J, Wilson K, Akbar S, Hayden I, Naseem Q, Worthington A, Coglan A, Hewson M, Young A, Fang M, Liu Y, Darke J, Wong V, Godbole G, Hughes GJ.   +14 more
europepmc   +1 more source

Injectables and Facelifts: Can We Coexist? A Retrospective Chart Review Assessing Injectable Treatments Preceding and Following Rhytidectomy. [PDF]

J Cosmet Dermatol
Myers B, Firsowicz M, Kamrani P, Dayan S, Fabi S.   +4 more
europepmc   +1 more source

Hypersensitivity Reactions Associated With Aesthetic Botulinum Toxin A Injections: A Case Series. [PDF]

Cureus
Buchholz E, Wanitphakdeedecha R, Jaturawichanant S, Pattanapran K, Corduff N.   +4 more
europepmc   +1 more source

Cross-Induction of Anti-Complexing Antibodies in Patients Treated with Botulinum Toxin Formulations Containing Complexing Proteins. [PDF]

Toxins (Basel)
Srinoulprasert Y, Sirisuthivoranunt S, Sripatumtong C, Tansit T, Yamlexnoi P, Meethong O, Wanitphakdeedecha R.   +6 more
europepmc   +1 more source

Comment on "Post-Botulinum Headache in Cosmetic Practice: A Prospective Study". [PDF]

J Cosmet Dermatol
Singh N, Srivastav M.
europepmc   +1 more source